XML 24 R11.htm IDEA: XBRL DOCUMENT v3.25.1
TDCC Consolidated Statements of Cash Flows Statement - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net income (loss) $ (290) $ 538
Depreciation and amortization 714 720
Provision (credit) for deferred income tax (177) 7
Earnings of nonconsolidated affiliates less than dividends received 133 75
Net periodic pension benefit credit (26) (48)
Pension contributions (31) (34)
Net gain on sales of assets, businesses and investments (2) (11)
Restructuring and asset related charges - net 208 45
Other net loss 185 92
Accounts and notes receivable (301) (600)
Inventories (221) (297)
Accounts payable 38 398
Other assets and liabilities, net (126) (425)
Cash provided by operating activities 91 464
Capital expenditures (685) (714)
Investment in gas field developments (30) (52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 3 2
Investments in and loans to nonconsolidated affiliates (3) (2)
Purchases of investments (104) (679)
Proceeds from sales and maturities of investments 416 1,173
Other investing activities, net 2 1
Cash used for investing activities (401) (271)
Changes in short-term notes payable (1) (20)
Proceeds from issuance of short-term debt greater than three months 11 7
Payments on short-term debt greater than three months (6) 0
Proceeds from issuance of long-term debt 1,013 1,381
Payments on long-term debt (957) (93)
Collections on securitization programs 15 4
Proceeds from issuance of stock 0 42
Transaction financing, debt issuance and other costs (64) (11)
Employee taxes paid for share-based payment arrangements (16) (37)
Distributions to noncontrolling interests (22) (14)
Dividends paid to stockholders (494) (493)
Cash provided by (used for) financing activities (521) 566
Effect of exchange rate changes on cash, cash equivalents and restricted cash 123 (54)
Increase (decrease) in cash, cash equivalents and restricted cash (708) 705
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period 1,555 3,753
Less: Restricted cash and cash equivalents, included in "Other current assets" 90 30
Cash and cash equivalents and end of period 1,465 3,723
The Dow Chemical Company    
Net income (loss) (288) 543
Depreciation and amortization 714 720
Provision (credit) for deferred income tax (177) 7
Earnings of nonconsolidated affiliates less than dividends received 133 75
Net periodic pension benefit credit (26) (48)
Pension contributions (31) (34)
Net gain on sales of assets, businesses and investments (2) (11)
Restructuring and asset related charges - net 208 45
Other net loss 185 92
Accounts and notes receivable (301) (600)
Inventories (221) (297)
Accounts payable 38 398
Other assets and liabilities, net (120) (421)
Cash provided by operating activities 112 469
Capital expenditures (685) (714)
Investment in gas field developments (30) (52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 3 2
Investments in and loans to nonconsolidated affiliates (3) (2)
Purchases of investments (104) (679)
Proceeds from sales and maturities of investments 416 1,173
Other investing activities, net 2 1
Cash used for investing activities (401) (271)
Changes in short-term notes payable (1) (20)
Proceeds from issuance of short-term debt greater than three months 11 7
Payments on short-term debt greater than three months (6) 0
Proceeds from issuance of long-term debt 1,013 1,381
Payments on long-term debt (957) (93)
Collections on securitization programs 15 4
Proceeds from issuance of stock 0 42
Transaction financing, debt issuance and other costs (64) (11)
Employee taxes paid for share-based payment arrangements (16) (37)
Distributions to noncontrolling interests (22) (14)
Dividends paid to stockholders (515) (698)
Cash provided by (used for) financing activities (542) 561
Effect of exchange rate changes on cash, cash equivalents and restricted cash 123 (54)
Increase (decrease) in cash, cash equivalents and restricted cash (708) 705
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period 1,555 3,753
Less: Restricted cash and cash equivalents, included in "Other current assets" 90 30
Cash and cash equivalents and end of period $ 1,465 $ 3,723